Daniel Odonnell, PA
Surgical · Oklahoma City, OKNPI 1952679979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $253 and has fallen 68.9% since, to $79 in 2025.
Across 18 payments — averaging $33.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$122
- Johnson & Johnson$118
- Si-bone, Inc.$86
- Dynasplint Systems Inc.$61
- Acumed LLC$43
- Bioventus LLC$38
- plus $139 from 5 others
What the payments were for
- Food & beverage$606100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $122 |
| Johnson & Johnson | 4 | $118 |
| Si-bone, Inc. | 2 | $86 |
| Dynasplint Systems Inc. | 1 | $61 |
| Acumed LLC | 1 | $43 |
| Bioventus LLC | 2 | $38 |
| ERMI LLC | 1 | $34 |
| Acera Surgical, Inc. | 1 | $31 |
| IBSA Pharma Inc. | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Nalu Medical, Inc. | 1 | $21 |
How this compares
$606 in reported general payments places this provider in the 55th percentile of 94 surgical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 91 | $912 |
| Gabapentin | 67 | $806 |
| Cyclobenzaprine Hcl | 43 | $534 |
| Diclofenac Sodium | 29 | $512 |
| Tizanidine Hcl | 24 | $355 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $130 |
| Cephalexin | 11 | $119 |
| Meloxicam | 13 | $71 |
| Tramadol Hcl | 15 | $40 |
| Amoxicillin | 19 | $29 |
Paid to pharmacies, not to this prescriber.
Other surgical in Oklahoma City
- Kayla HaleOklahoma City$36K
- Randall PapeOklahoma City$25K
- Ian GordonOklahoma City$14K
- Eduardo GarciaOklahoma City$4K
- Lauren HinkOklahoma City$3K
- Nathan CharltonOklahoma City$2K
- Stephanie GarrisonOklahoma City$2K
- Katrina StewartOklahoma City$2K
- Elizabeth LittleOklahoma City$849
- Dustin WagnerOklahoma City$837
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.